This document provides an overview of Beyond A Century, Inc.'s (BAC) current good manufacturing practices (GMP) program for packaging, labeling, and holding dietary supplements. It describes BAC's personnel requirements and training, facility design and maintenance, production and process controls, quality control testing, and Hazard Analysis and Critical Control Point (HACCP) plan. The HACCP plan identifies potential biological, chemical, and physical hazards at critical control points during receiving, sampling, storage, production, and shipping. It establishes monitoring, corrective actions, verification, and documentation procedures to control these hazards and prevent product adulteration.
This document outlines the Good Manufacturing Practice (GMP) regulations in India as specified in Schedule M. It discusses 16 sections covering various aspects of GMP compliance, including premises and equipment requirements, production procedures, sanitation, quality control testing, documentation, and self-inspection. The goal of GMP regulations is to ensure pharmaceutical products are consistently manufactured and controlled according to quality standards appropriate for their intended use.
The document outlines GMP requirements related to personnel, training, hygiene, premises design and layout, warehouse, production and auxiliary areas, and quality control. It emphasizes that facilities, equipment, and personnel must be suitable for manufacturing pharmaceutical products and maintaining quality. Key responsibilities are defined for heads of production and quality units to ensure compliance with GMP standards.
This document discusses Good Manufacturing Practices (GMP) for sterile pharmaceutical products. It provides an agenda that covers requirements for facilities, equipment, processes, and documentation for sterile manufacturing. Key points include maintaining proper air handling systems with appropriate air classification grades for different areas. Environmental monitoring, garment requirements, sanitation procedures, equipment specifications, and detailed manufacturing and batch documentation standards are also outlined to ensure sterile products are consistently manufactured and controlled to quality standards.
This document provides information on the requirements for factory premises for manufacturing homeopathic preparations, cosmetics, and medical devices. It discusses the general requirements for location, buildings, water supply, waste disposal, and staff hygiene. It also outlines the specific plant and equipment needed for producing different types of homeopathic preparations like syrups and ointments, various cosmetic products like powders and creams, and medical devices like perfusion sets, syringes, and their component areas for molding, assembling, storage, washing, drying, sealing, sterilization, and testing.
Hygiene standards and procedures usually described as Good Hygienic Practices (GHP) or Good Manufacturing Practices (GMP), have been in place for many years and constituted an essential tool in traditional food control. These concepts are still essential in a modern food control system by providing the basic environmental and operating conditions for production of safe food and thus being a requisite or foundation for HACCP in an overall food safety management program. What is new is the concept of formalizing the prerequisite program alongside HACCP and the legal requirement in some countries (USA) of documented monitoring of certain sanitation areas.
1. The document discusses Good Manufacturing Practices (GMP) regulations for Schedule M drugs and cosmetics in India.
2. It covers GMP requirements for premises, equipment, sanitation, personnel, production, quality control, documentation and other areas to ensure consistent high quality of pharmaceutical products.
3. Key aspects include requirements for manufacturing facilities, warehouses, equipment calibration, personnel training, hygiene, production supervision, validation of cleaning procedures, and maintenance of records to allow traceability of all manufacturing steps.
The document discusses GMP requirements related to personnel, training, hygiene, premises design and maintenance, and quality control. It states that there must be sufficient qualified personnel with defined responsibilities and records. Training programs should be in place for all personnel. Hygiene practices like health checks, hand washing, and protective clothing are required. Premises must be designed and maintained to minimize risks to product quality from things like dust, pests and airflow. Areas for storage, production, and quality control should be separate and suitable for their intended purposes. Regular maintenance is important to avoid contamination and ensure smooth operations.
This document outlines the Good Manufacturing Practice (GMP) regulations in India as specified in Schedule M. It discusses 16 sections covering various aspects of GMP compliance, including premises and equipment requirements, production procedures, sanitation, quality control testing, documentation, and self-inspection. The goal of GMP regulations is to ensure pharmaceutical products are consistently manufactured and controlled according to quality standards appropriate for their intended use.
The document outlines GMP requirements related to personnel, training, hygiene, premises design and layout, warehouse, production and auxiliary areas, and quality control. It emphasizes that facilities, equipment, and personnel must be suitable for manufacturing pharmaceutical products and maintaining quality. Key responsibilities are defined for heads of production and quality units to ensure compliance with GMP standards.
This document discusses Good Manufacturing Practices (GMP) for sterile pharmaceutical products. It provides an agenda that covers requirements for facilities, equipment, processes, and documentation for sterile manufacturing. Key points include maintaining proper air handling systems with appropriate air classification grades for different areas. Environmental monitoring, garment requirements, sanitation procedures, equipment specifications, and detailed manufacturing and batch documentation standards are also outlined to ensure sterile products are consistently manufactured and controlled to quality standards.
This document provides information on the requirements for factory premises for manufacturing homeopathic preparations, cosmetics, and medical devices. It discusses the general requirements for location, buildings, water supply, waste disposal, and staff hygiene. It also outlines the specific plant and equipment needed for producing different types of homeopathic preparations like syrups and ointments, various cosmetic products like powders and creams, and medical devices like perfusion sets, syringes, and their component areas for molding, assembling, storage, washing, drying, sealing, sterilization, and testing.
Hygiene standards and procedures usually described as Good Hygienic Practices (GHP) or Good Manufacturing Practices (GMP), have been in place for many years and constituted an essential tool in traditional food control. These concepts are still essential in a modern food control system by providing the basic environmental and operating conditions for production of safe food and thus being a requisite or foundation for HACCP in an overall food safety management program. What is new is the concept of formalizing the prerequisite program alongside HACCP and the legal requirement in some countries (USA) of documented monitoring of certain sanitation areas.
1. The document discusses Good Manufacturing Practices (GMP) regulations for Schedule M drugs and cosmetics in India.
2. It covers GMP requirements for premises, equipment, sanitation, personnel, production, quality control, documentation and other areas to ensure consistent high quality of pharmaceutical products.
3. Key aspects include requirements for manufacturing facilities, warehouses, equipment calibration, personnel training, hygiene, production supervision, validation of cleaning procedures, and maintenance of records to allow traceability of all manufacturing steps.
The document discusses GMP requirements related to personnel, training, hygiene, premises design and maintenance, and quality control. It states that there must be sufficient qualified personnel with defined responsibilities and records. Training programs should be in place for all personnel. Hygiene practices like health checks, hand washing, and protective clothing are required. Premises must be designed and maintained to minimize risks to product quality from things like dust, pests and airflow. Areas for storage, production, and quality control should be separate and suitable for their intended purposes. Regular maintenance is important to avoid contamination and ensure smooth operations.
The Sigma Test and Research Center provide testing and research facilities worldwide. Visit our website http://bit.ly/2HVkg21 and book your testing and research services. Our testing and research services rates are very cheap and our work is always quality work.
This document outlines good manufacturing practices and requirements for pharmaceutical manufacturing facilities. It discusses requirements for premises, buildings, warehousing, production, quality control, personnel, and operations. Specifically, it addresses the following key points:
1. Facilities must be designed and maintained to ensure hygienic manufacturing conditions and prevent contamination.
2. Separate dedicated areas are required for sensitive products like antibiotics and hazardous materials.
3. Production, quality control, and ancillary areas like personnel facilities must be separated.
4. Strict personnel hygiene practices and medical monitoring are required.
5. Manufacturing operations must be well-controlled and supervised to prevent mix-ups or
The document outlines good manufacturing practices (GMP) that must be followed to produce safe products. It discusses personnel hygiene practices, facility requirements, storage practices, process equipment guidelines, cleaning and sanitation procedures, pest control measures, and documentation standards that are necessary to ensure product quality and safety.
This document outlines Good Manufacturing Practices (GMP) guidelines for drug manufacturing facilities. It addresses requirements for facility premises, materials, production areas, quality control, personnel, and sanitation. Key requirements include preventing contamination risks through proper building/area design, segregation of incompatible operations, control of air handling systems, cleaning procedures, personnel training, and health/hygiene practices. The guidelines are intended to ensure consistent high quality drug production under hygienic conditions.
GMP, Goods manufacturer Practices, Drug and Cosmetic actDrSampuranSuahg
GMP (good manufacturing practices) regulations ensure that pharmaceutical products are consistently manufactured and controlled according to quality standards. Key aspects of GMP include maintaining high standards for facilities, equipment, production processes, packaging and labeling, quality control testing, record keeping, and personnel qualifications. GMP helps to minimize risks of contamination and ensures that products meet specifications for identity, strength, quality, purity and safety.
This document outlines good manufacturing practices (GMP) for Ayurvedic, Siddha, and Unani medicines. It discusses infrastructure requirements for manufacturing facilities, including adequate space for receiving raw materials, manufacturing, quality control, finished goods storage, and offices. It also covers requirements for buildings, water supply, waste disposal, cleaning of containers, storage, and machinery/equipment. Worker health, clothing, sanitation, and medical services are also addressed. The objective is to ensure raw materials are authentic and contamination-free, manufacturing follows the proper process, quality control measures are in place, and the finished drug is of acceptable quality.
This document discusses good manufacturing practices related to sanitation, prevention of cross-contamination and mix-ups, and processing of intermediates. It emphasizes that premises must be designed and maintained for good sanitation. Strict procedures and controls are needed to prevent cross-contamination between products during production through measures like segregation, air handling, cleaning, and labeling. Intermediates must also be stored and handled carefully according to specifications. Thorough cleaning and changeover procedures are required when switching between products to avoid mix-ups.
This document outlines good manufacturing practices (GMP) for premises, materials, equipment, and documentation used in pharmaceutical manufacturing. It discusses requirements for building location and design, waste disposal, water systems, storage areas, production areas, personnel, and sanitation. Specific guidelines are provided for raw material receipt and storage, manufacturing operations, equipment use and maintenance, and documentation and record keeping. The goal is to ensure proper conditions and controls are in place to prevent mix-ups, contamination, and to allow for efficient production of quality pharmaceutical products.
Quality of drugs is basically responsibility of manufacturers & GMP guidelines are a means to assure very quality.
Draft of GMP regulations was prepared in 1975 which could be finalized & implemented in 1988, in form of amended schedule M.
It embraces Rule 71,74,76 & 78 under D & C Rules 1945.
To achieve objectives of GMP, licensee shall comply with requirements of GMP as laid down in Schedule M.
Part I deals with GMP relating to factory premises, & Part II deals with plant & equipment for manufacture of drugs.
GMP is a set of principles and procedures that ensure products are consistently manufactured and controlled according to quality standards for their intended use. Key aspects of GMP include requirements for facilities, equipment, personnel, documentation, raw materials, production, packaging and labeling, quality control, self-inspection and product recalls. GMP regulations in India were introduced in 1988 and amended in 2001, embracing rules under the Drugs and Cosmetics Rules 1945. Facilities must be designed and maintained to allow production under hygienic conditions in order to prevent contamination and cross-contamination.
PHARMACEUTICAL PRODUCTION MANAGEMENT & INVENTORY CONTROLArunpandiyan59
1. The document outlines requirements for modern pharmaceutical production facilities including location, building design, waste disposal, storage, production, and quality control. Key requirements include preventing contamination, ensuring hygienic conditions, and separating different categories of drugs.
2. Specific sections cover water treatment systems, warehousing, production area layout, quality control laboratory independence, personnel training, and inventory/raw material management. Equipment must be properly located, maintained and defective units removed.
3. Quality assurance systems must ensure pharmaceutical products meet GMP standards and are developed to requirements for design, development, manufacturing and quality management.
This document provides information on current good manufacturing practices (CGMP) regulations enforced by the FDA to ensure quality in pharmaceutical manufacturing. It discusses the importance of CGMP for quality products, customer satisfaction, consistency and company reputation. The objectives are to understand regulatory requirements and minimize risks that can't be detected by final testing. The document outlines various CGMP guidelines related to facilities, equipment, personnel, documentation, batch records, quality control and more. It provides details on specific areas like premises, warehousing, water systems, waste disposal, production areas and equipment cleaning/validation.
Sanitation in manufacturing premises is essential to prevent contamination of products. It requires keeping all areas clean, including the premises, manufacturing areas, equipment, and personnel. This involves removing dirt, waste, garbage and other sources of infection or disease. Cleaning and sanitation of premises and equipment helps ensure products are not contaminated during the manufacturing, processing, packing or holding of drug products.
This document provides an overview of current good manufacturing practice (cGMP) guidelines for active pharmaceutical ingredients (APIs) according to the US Food and Drug Administration (FDA). It discusses cGMP requirements for personnel responsibilities and training, facility design and maintenance, process utilities, containment practices, documentation and record keeping, and control of contamination during API manufacturing. The document is intended to provide guidance on complying with cGMP standards to ensure the quality of APIs.
Manufacturing operations and controls are important to ensure the identity, strength, safety, and purity of pharmaceutical products. Key aspects include sanitizing manufacturing premises, preventing mix-ups and cross contamination, processing intermediates and bulk products while maintaining quality, conducting packaging operations with controls, in-process quality control testing during manufacturing and packaging, and only releasing finished products that meet all requirements after quality approval. Maintaining proper documentation and investigating any deviations or unusual events are also important parts of manufacturing and quality control.
This document provides an overview of good manufacturing practices (GMP) for pharmaceutical plants. It discusses the key requirements related to surroundings, general plant facilities, specific department areas like storage, production, quality control, and sterile products. Requirements include minimizing risk of contamination, maintaining clean and sanitary conditions, separate areas for different functions, and controls for temperature, humidity and air quality. GMP is designed to consistently produce quality products that meet standards.
cGMP as per shedule M outlines the Good Manufacturing Practices that must be followed for pharmaceutical manufacturing according to the Drugs and Cosmetics Act of India. It covers requirements for facilities, equipment, personnel, sanitation, documentation, quality control, packaging and labeling. All aspects of production from raw materials to finished products must meet GMP standards to ensure consistency and quality of manufactured drugs. Detailed written procedures and records are required for all manufacturing processes.
Concept of rasashala w.s.r to gmp guidelinesDr Ganesh Naik
The document discusses Good Manufacturing Practices (GMP) for herbo-mineral Ayurvedic drugs. It defines GMP and current GMP (cGMP), and explains their importance in meeting worldwide demand while ensuring drug quality and safety. It outlines the key requirements for facilities, equipment, personnel, processes, quality control, packaging, and hygiene. Implementing GMP for herbo-mineral drugs per Indian law is challenging but necessary to protect consumers and access international markets.
Good manufacturing practices (GMP) regulations ensure consistency and quality in pharmaceutical manufacturing. GMP covers facilities, equipment, personnel, production, packaging and quality control. Key requirements include designated clean areas for operations, qualified personnel, documented procedures, process validation, environmental monitoring, component testing and record keeping. GMP aims to prevent contamination and errors through strict quality standards at all stages of production.
This document outlines the requirements for factory premises manufacturing medical devices according to Schedule M-III of the Drugs and Cosmetics Rules 1945 in India. It discusses location, building, water supply, waste disposal, worker hygiene and medical facilities requirements. It also provides recommendations for equipment and space needed for manufacturing common medical devices like perfusion sets, syringes and needles. Manufacturers must follow good manufacturing practices and maintain processing and quality control records. Medical devices are classified based on risk into four classes from low to high risk.
How do a startup company's potential resources and costs connect to their future impacts? Better by Measure, a class from the Products of Design masters program at the School of Visual Arts (http://productsofdesign.sva.edu), explores how startups can build value by critically embracing civic, environmental, and human health challenges. The course is taught by Jen van der Meer (@jenvandermeer) and Rebecca Silver (@rgsilver).
This document provides instructions for using Google Maps to view U.S. congressional districts and determine the representative of seven different cities. It explains how to configure the Google Maps layers to display only congressional district borders and labels. Screenshots demonstrate the desired congressional map view. Users are then prompted to identify the representative for each of the seven cities listed.
The Sigma Test and Research Center provide testing and research facilities worldwide. Visit our website http://bit.ly/2HVkg21 and book your testing and research services. Our testing and research services rates are very cheap and our work is always quality work.
This document outlines good manufacturing practices and requirements for pharmaceutical manufacturing facilities. It discusses requirements for premises, buildings, warehousing, production, quality control, personnel, and operations. Specifically, it addresses the following key points:
1. Facilities must be designed and maintained to ensure hygienic manufacturing conditions and prevent contamination.
2. Separate dedicated areas are required for sensitive products like antibiotics and hazardous materials.
3. Production, quality control, and ancillary areas like personnel facilities must be separated.
4. Strict personnel hygiene practices and medical monitoring are required.
5. Manufacturing operations must be well-controlled and supervised to prevent mix-ups or
The document outlines good manufacturing practices (GMP) that must be followed to produce safe products. It discusses personnel hygiene practices, facility requirements, storage practices, process equipment guidelines, cleaning and sanitation procedures, pest control measures, and documentation standards that are necessary to ensure product quality and safety.
This document outlines Good Manufacturing Practices (GMP) guidelines for drug manufacturing facilities. It addresses requirements for facility premises, materials, production areas, quality control, personnel, and sanitation. Key requirements include preventing contamination risks through proper building/area design, segregation of incompatible operations, control of air handling systems, cleaning procedures, personnel training, and health/hygiene practices. The guidelines are intended to ensure consistent high quality drug production under hygienic conditions.
GMP, Goods manufacturer Practices, Drug and Cosmetic actDrSampuranSuahg
GMP (good manufacturing practices) regulations ensure that pharmaceutical products are consistently manufactured and controlled according to quality standards. Key aspects of GMP include maintaining high standards for facilities, equipment, production processes, packaging and labeling, quality control testing, record keeping, and personnel qualifications. GMP helps to minimize risks of contamination and ensures that products meet specifications for identity, strength, quality, purity and safety.
This document outlines good manufacturing practices (GMP) for Ayurvedic, Siddha, and Unani medicines. It discusses infrastructure requirements for manufacturing facilities, including adequate space for receiving raw materials, manufacturing, quality control, finished goods storage, and offices. It also covers requirements for buildings, water supply, waste disposal, cleaning of containers, storage, and machinery/equipment. Worker health, clothing, sanitation, and medical services are also addressed. The objective is to ensure raw materials are authentic and contamination-free, manufacturing follows the proper process, quality control measures are in place, and the finished drug is of acceptable quality.
This document discusses good manufacturing practices related to sanitation, prevention of cross-contamination and mix-ups, and processing of intermediates. It emphasizes that premises must be designed and maintained for good sanitation. Strict procedures and controls are needed to prevent cross-contamination between products during production through measures like segregation, air handling, cleaning, and labeling. Intermediates must also be stored and handled carefully according to specifications. Thorough cleaning and changeover procedures are required when switching between products to avoid mix-ups.
This document outlines good manufacturing practices (GMP) for premises, materials, equipment, and documentation used in pharmaceutical manufacturing. It discusses requirements for building location and design, waste disposal, water systems, storage areas, production areas, personnel, and sanitation. Specific guidelines are provided for raw material receipt and storage, manufacturing operations, equipment use and maintenance, and documentation and record keeping. The goal is to ensure proper conditions and controls are in place to prevent mix-ups, contamination, and to allow for efficient production of quality pharmaceutical products.
Quality of drugs is basically responsibility of manufacturers & GMP guidelines are a means to assure very quality.
Draft of GMP regulations was prepared in 1975 which could be finalized & implemented in 1988, in form of amended schedule M.
It embraces Rule 71,74,76 & 78 under D & C Rules 1945.
To achieve objectives of GMP, licensee shall comply with requirements of GMP as laid down in Schedule M.
Part I deals with GMP relating to factory premises, & Part II deals with plant & equipment for manufacture of drugs.
GMP is a set of principles and procedures that ensure products are consistently manufactured and controlled according to quality standards for their intended use. Key aspects of GMP include requirements for facilities, equipment, personnel, documentation, raw materials, production, packaging and labeling, quality control, self-inspection and product recalls. GMP regulations in India were introduced in 1988 and amended in 2001, embracing rules under the Drugs and Cosmetics Rules 1945. Facilities must be designed and maintained to allow production under hygienic conditions in order to prevent contamination and cross-contamination.
PHARMACEUTICAL PRODUCTION MANAGEMENT & INVENTORY CONTROLArunpandiyan59
1. The document outlines requirements for modern pharmaceutical production facilities including location, building design, waste disposal, storage, production, and quality control. Key requirements include preventing contamination, ensuring hygienic conditions, and separating different categories of drugs.
2. Specific sections cover water treatment systems, warehousing, production area layout, quality control laboratory independence, personnel training, and inventory/raw material management. Equipment must be properly located, maintained and defective units removed.
3. Quality assurance systems must ensure pharmaceutical products meet GMP standards and are developed to requirements for design, development, manufacturing and quality management.
This document provides information on current good manufacturing practices (CGMP) regulations enforced by the FDA to ensure quality in pharmaceutical manufacturing. It discusses the importance of CGMP for quality products, customer satisfaction, consistency and company reputation. The objectives are to understand regulatory requirements and minimize risks that can't be detected by final testing. The document outlines various CGMP guidelines related to facilities, equipment, personnel, documentation, batch records, quality control and more. It provides details on specific areas like premises, warehousing, water systems, waste disposal, production areas and equipment cleaning/validation.
Sanitation in manufacturing premises is essential to prevent contamination of products. It requires keeping all areas clean, including the premises, manufacturing areas, equipment, and personnel. This involves removing dirt, waste, garbage and other sources of infection or disease. Cleaning and sanitation of premises and equipment helps ensure products are not contaminated during the manufacturing, processing, packing or holding of drug products.
This document provides an overview of current good manufacturing practice (cGMP) guidelines for active pharmaceutical ingredients (APIs) according to the US Food and Drug Administration (FDA). It discusses cGMP requirements for personnel responsibilities and training, facility design and maintenance, process utilities, containment practices, documentation and record keeping, and control of contamination during API manufacturing. The document is intended to provide guidance on complying with cGMP standards to ensure the quality of APIs.
Manufacturing operations and controls are important to ensure the identity, strength, safety, and purity of pharmaceutical products. Key aspects include sanitizing manufacturing premises, preventing mix-ups and cross contamination, processing intermediates and bulk products while maintaining quality, conducting packaging operations with controls, in-process quality control testing during manufacturing and packaging, and only releasing finished products that meet all requirements after quality approval. Maintaining proper documentation and investigating any deviations or unusual events are also important parts of manufacturing and quality control.
This document provides an overview of good manufacturing practices (GMP) for pharmaceutical plants. It discusses the key requirements related to surroundings, general plant facilities, specific department areas like storage, production, quality control, and sterile products. Requirements include minimizing risk of contamination, maintaining clean and sanitary conditions, separate areas for different functions, and controls for temperature, humidity and air quality. GMP is designed to consistently produce quality products that meet standards.
cGMP as per shedule M outlines the Good Manufacturing Practices that must be followed for pharmaceutical manufacturing according to the Drugs and Cosmetics Act of India. It covers requirements for facilities, equipment, personnel, sanitation, documentation, quality control, packaging and labeling. All aspects of production from raw materials to finished products must meet GMP standards to ensure consistency and quality of manufactured drugs. Detailed written procedures and records are required for all manufacturing processes.
Concept of rasashala w.s.r to gmp guidelinesDr Ganesh Naik
The document discusses Good Manufacturing Practices (GMP) for herbo-mineral Ayurvedic drugs. It defines GMP and current GMP (cGMP), and explains their importance in meeting worldwide demand while ensuring drug quality and safety. It outlines the key requirements for facilities, equipment, personnel, processes, quality control, packaging, and hygiene. Implementing GMP for herbo-mineral drugs per Indian law is challenging but necessary to protect consumers and access international markets.
Good manufacturing practices (GMP) regulations ensure consistency and quality in pharmaceutical manufacturing. GMP covers facilities, equipment, personnel, production, packaging and quality control. Key requirements include designated clean areas for operations, qualified personnel, documented procedures, process validation, environmental monitoring, component testing and record keeping. GMP aims to prevent contamination and errors through strict quality standards at all stages of production.
This document outlines the requirements for factory premises manufacturing medical devices according to Schedule M-III of the Drugs and Cosmetics Rules 1945 in India. It discusses location, building, water supply, waste disposal, worker hygiene and medical facilities requirements. It also provides recommendations for equipment and space needed for manufacturing common medical devices like perfusion sets, syringes and needles. Manufacturers must follow good manufacturing practices and maintain processing and quality control records. Medical devices are classified based on risk into four classes from low to high risk.
How do a startup company's potential resources and costs connect to their future impacts? Better by Measure, a class from the Products of Design masters program at the School of Visual Arts (http://productsofdesign.sva.edu), explores how startups can build value by critically embracing civic, environmental, and human health challenges. The course is taught by Jen van der Meer (@jenvandermeer) and Rebecca Silver (@rgsilver).
This document provides instructions for using Google Maps to view U.S. congressional districts and determine the representative of seven different cities. It explains how to configure the Google Maps layers to display only congressional district borders and labels. Screenshots demonstrate the desired congressional map view. Users are then prompted to identify the representative for each of the seven cities listed.
The CEO of DEWA and the President of General Electric Gulf discussed developments in energy transformation and renewable energy. They reviewed DEWA's current and ongoing projects and discussed efforts to develop new technologies. The President of GE Gulf outlined solutions and techniques offered by GE for renewable energy, technology, and investments.
This document is a resume for Pilar Munoz-Najar, an urban and environmental planner. It outlines her education including a Master's degree in Urban and Environmental Planning from Griffith University, as well as degrees in architecture. It details her professional experience including roles as an onsite supervisor, project coordinator, and architecture intern. It also lists her skills such as GIS mapping and various software, and provides referees.
El documento proporciona información sobre virus informáticos y antivirus. Explica que los antivirus son programas diseñados para detectar y eliminar virus de computadoras. Luego describe brevemente la historia de los virus y antivirus, y resume los principales tipos de virus como troyanos, gusanos e infectores de sistema autoreplicables. Finalmente, menciona algunos de los antivirus más populares como McAfee, AVG, Avast, Kaspersky y NOD32.
El documento proporciona información sobre el uso de Facebook para comercios y pymes. Explica qué es Facebook, las ventajas de utilizarlo para un negocio, cómo crear y gestionar una página de Facebook para una empresa, y los diferentes tipos de contenido que se pueden publicar en una página de Facebook, como publicaciones, fotos, eventos y ofertas.
Los sistemas de gestión del aprendizaje (LMS) se utilizan para crear, administrar, almacenar y distribuir actividades de formación virtual. Existen tres tipos de LMS: comerciales, de software libre y en la nube. Los LMS comerciales son de uso licenciado y suelen ser más robustos, mientras que los de software libre son gratuitos pero menos completos. Los LMS en la nube se usan principalmente para apoyar la enseñanza presencial y los cursos masivos en línea.
This document provides an overview of sterile production requirements including:
1) Different sterile product types and their air classification requirements for different production steps.
2) Key GMP requirements for sterile facilities including air quality grades, environmental monitoring, and personnel requirements.
3) Sterilization methods including heat, filtration, radiation and ethylene oxide gas. Validation and process monitoring requirements are discussed.
4) Quality control testing requirements for sterility, endotoxins and environmental monitoring are summarized.
Este documento describe los neurotransmisores, sustancias químicas que transmiten señales entre neuronas. Explica que la acetilcolina y la noradrenalina son los principales neurotransmisores del sistema nervioso periférico, mientras que en el sistema nervioso central también funcionan la dopamina y otros. Los neurotransmisores se clasifican en colinérgicos, adrenérgicos, aminoacídicos y peptídicos. Finalmente, resume cómo se produce la transmisión del impulso nervioso a través de las sinapsis mediante la
Shiv Nadar is the founder and chairman of HCL Technologies, one of India's largest IT companies. He established HCL in 1976 and grew it into a multinational conglomerate with over $4 billion in revenue. Through his Shiv Nadar Foundation, he supports educational institutions like SSN College of Engineering and Vidyagyan schools for underprivileged students. Nadar has received several honors and awards for his contributions to the IT industry and philanthropy in India.
Reliance Digital's CRM policy focuses on customer loyalty, retention, communication and gratification. It maintains customer records to categorize them and communicates through SMS, email, mobile vans and print media. It also surveys customers to measure satisfaction levels and handles complaints by logging them, acknowledging receipt, formulating solutions, responding to address issues, and following up.
Good Manufacturing Practices (GMP) regulations were introduced in 1988 and amended in 2001 to ensure pharmaceutical products are consistently produced and controlled according to quality standards. GMP covers all aspects of production from starting materials to training and hygiene of staff. Detailed written procedures and documented proof of following correct procedures are required at each step of manufacturing. The goal is to minimize risks that cannot be detected by final testing and ensure consumers receive products of the specified quality.
This presentation describes Schedule M of Drugs & Cosmetic Act. It consists of Good Manufacturing Practices (GMP) for the manufacturing of drugs. Detailed guidelines about factory premises, machinery, process, quality control, etc. have been given.
This document defines key terms related to Good Manufacturing Practice (GMP) for pharmaceuticals. It discusses GMP requirements for facilities, equipment, documentation, materials, processes, quality control, quality assurance, personnel, sanitation, complaints, and recalls. Key points include that GMP aims to consistently produce quality medicines through validated processes and facilities, qualified staff, appropriate materials and equipment, and defined procedures. Quality assurance covers all activities influencing quality, while quality control tests and releases products. Personnel must be properly trained and hygienic practices followed.
This document discusses Good Manufacturing Practices (GMP) and current Good Manufacturing Practices (cGMP). It provides definitions of GMP and cGMP, explaining that GMP ensures quality and safety in manufacturing while cGMP refers specifically to FDA regulations. The principles and regulations of GMP, cGMP, and their comparison are outlined. Key aspects like facilities, equipment, documentation, packaging and labeling, quality control, and standard operating procedures are summarized.
Tony seruga yolanda seruga business expert. Tony Seruga Yolanda Seruga hates scam and fraud and any kinds of ripoff. Tony Seruga a business i con knows pros and cons and has got very good reviews as he got the best review of internet marketer.In the early years, Tony Seruga started a professional lawn service, employing college kids to do the actual work when he was only 14 years old building revenues to over $12,000 per year by the time he was 17. Tony built his first computer from a kit in 1976 and started his first “online” business in the early 1980s, using AOL and Compuserve.
Tony is a serial entrepreneur, having personally started over 240 businesses and over 600 with business partners. Tony has mentored thousands upon thousands of business owners.
Tony has been an early stage investor and entrepreneur since 1987. Tony has over two decades of experience in the venture capital, technology and entertainment industries in a multitude of investing, operational and engineering roles acting as a key adviser. In addition to his investing efforts, Tony has been active with several non-profit organizations. Tony holds a Juris Doctorate, although he never chose to practice law, opting for buying and selling businesses and investing in those projects he felt had the best chance of success.
Tony was co-owner of half a dozen early search engines including three pay-per-click search engines and was an early angel investor and adviser to four different businesses that went on to become multi-billion dollar companies. As a business adviser, Tony’s past client roster included a number of household names and celebrities.
And while Tony enjoyed speaking at business and marketing events all over the world, his real passion is to empower entrepreneurs and business owners to create massive success. Tony loves to help people to understand specifically what it takes to build a successful business. He has a very successful background in venture capital, investing and marketing. He has spent two decades working with start-ups to major global brands increasing sales, productivity and overall success and is an innovator with a remarkable ability to determine and dictate success strategies that enable companies to seize global market opportunities.
For everyone that either wishes to start their own business, currently owns a business or would like to capitalize the entrepreneurial dream, Tony’s message will enlighten them with knowledge and actionable principles to turn that passion into success. Tony has an extensive background in starting businesses, commercial real estate development and building companies around the world. Over the past two decades, he has specialized in helping companies launch, grow and create exponential valuation in the marketplace.
For more info about Tony Seruga visit http://tonyserugatonyserugatonyseruga.blogspot.com/
This document discusses project planning and food safety systems. It provides an overview of project planning stages including preparing a project overview, developing an activity plan, assigning responsibilities, implementing the plan, and creating a closeout report. It also discusses prerequisites for project planning. The document then focuses on Hazard Analysis and Critical Control Point (HACCP) and Good Manufacturing Practices (GMP), outlining the key steps and aspects of each system. HACCP is described as a food safety management system used to identify and control biological, chemical, and physical hazards, while GMP covers sanitation, maintenance, and personnel practices.
This document defines Good Manufacturing Practice (GMP) and outlines its history and key regulations. GMP is a set of guidelines for ensuring products are consistently produced and controlled according to quality standards for their intended use. Major developments include the 1962 Thalidomide tragedy leading to GMP regulations, and guidelines published by organizations like WHO, FDA, and other national regulatory agencies. The document describes key aspects of GMP including facilities, equipment, production processes, packaging and labeling, quality control, and record keeping.
Introduction to manufacturing operations, Sanitation, Cross-contamination, Packaging, IPQC, time limitation, Expiration,Calculation of Yield, Production record review, process deviation
This document outlines good manufacturing practices (GMPs) for cosmetics manufacturing. It discusses establishing a quality management system and quality assurance programs. Personnel should be adequately trained. Premises, equipment, and production processes should be designed and maintained to minimize risks of contamination. Thorough documentation, quality control testing, and complaint handling are required. The GMPs are intended to assure consistent high quality products that are safe for consumers.
The document discusses Good Manufacturing Practices (GMP) for pharmaceutical manufacturing. It outlines requirements for facilities, equipment, personnel, documentation, production processes, quality control, and other operational aspects to minimize risks and ensure consistent production of quality products. GMP covers all aspects of production and testing to maintain standards, prevent contamination and errors, and comply with regulatory guidelines.
This document provides an overview of requirements for Good Manufacturing Practices (GMP), Current Good Manufacturing Practices (cGMP), Good Laboratory Practices (GLP), USFDA guidelines, and ISO 9000 standards. It discusses key elements of GMP/cGMP including facilities, equipment, documentation, quality control, and compliance. It also outlines 10 key principles of GLP relating to test facility organization, quality assurance, facilities, equipment, test systems, substances, standard operating procedures, performance, reporting and record keeping. The document is intended to present information on regulatory standards for pharmaceutical manufacturing and laboratory testing.
The document discusses current Good Manufacturing Practices (cGMP) according to the US Food and Drug Administration (FDA). It provides an overview of cGMP principles and requirements, including proper facilities and equipment design, documentation practices, and quality control. The document also summarizes key cGMP regulations and guidelines for manufacturing, processing, packaging, holding, testing, and distributing drug products. It outlines the important documents, facilities, equipment, production processes, and quality systems that must be in place to ensure consistent production of safe, effective pharmaceuticals.
This document outlines Good Manufacturing Practices (GMP) for producing sterile pharmaceutical products. It discusses that GMP ensures products are consistently manufactured and controlled to quality standards for their intended use. Specific requirements are provided for facilities, equipment, environmental controls, personnel hygiene and sanitation practices when manufacturing sterile injectables, ophthalmic preparations and other sterile products to minimize risks of contamination. Production must follow documented procedures and strict aseptic techniques to ensure the sterility and quality of manufactured medicines.
Quality control measures in pharmaceutical industryChemOnTheGo
QUALITY CONTROL
ROLE OF QUALITY CONTROL IN PHARMACEUTICAL INDUSTRY
OBJECTIVES OF QUALITY CONTROL
STEPS IN QUALITY CONTROL
COST OF QUALITY CONTROL
TOTAL QUALITY MANAGEMENT
QUALITY CIRCLE
GMP, GLP, and GHP are quality control standards used in various industries to ensure safe and consistent production. GMP focuses on plant design, machinery, pest control, personnel hygiene, cleaning procedures, hazard monitoring, and traceability. Key elements of GLP include management responsibilities, study planning, personnel roles, facilities, equipment, and approved test methods. Together, these standards help ensure products are manufactured and tested according to international guidelines, protecting consumers and the environment.
The document outlines the Good Manufacturing Practices (GMP) as per Schedule M of the Drugs and Cosmetic Act of 1940 in India. It details the requirements for facilities, equipment, production, quality control, documentation, personnel and other aspects of pharmaceutical manufacturing. The key points covered include requirements for premises location, building design to prevent contamination, waste disposal procedures, manufacturing controls, quality control testing, documentation and record keeping, personnel qualifications, and compliance with other applicable regulations.
The document discusses good manufacturing practices (GMP) and food safety. It defines GMP as quality assurance to ensure food meets quality and safety standards required for its intended use. GMP covers all aspects of manufacturing from processes and facilities to personnel, documentation, and product tracing. Food plants must implement pest control and maintain sanitary facilities, equipment, and employee hygiene practices. Buildings should be designed for cleanability, segregation of raw and finished goods, and protection from pests. The Codex Alimentarius Commission establishes international food safety standards including GMP and Hazard Analysis and Critical Control Point programs.
IMMUNOLOGY (for medical student) pharmacy departmentSlientNight
This document outlines guidelines for good manufacturing practices (GMP) to control microbial contamination during pharmaceutical production. It discusses performing risk assessments and maintaining environmental cleanliness. Starting materials must meet quality standards and water quality must be controlled. Strict quality control, documentation, packaging, and storage procedures are required. Facilities for sterile production must be properly designed, cleaned, and maintained in aseptic clean rooms with appropriate air handling. Regulatory authorities require GMP compliance for pharmaceutical licenses.
Prerequisite programs are hygiene and sanitation programs that must be in place to ensure a safe manufacturing environment according to food safety standards like ISO 22000. The key programs addressed in the document include: site and building construction/maintenance, equipment cleaning and maintenance, pest control, waste disposal, cleaning programs, water/utility quality, ingredient and supplier management, and prevention of contamination. The document provides an overview of the general requirements for each prerequisite program to maintain sanitary conditions and protect against food safety hazards.
The document discusses regulations related to good clinical practices (GCPs) and good manufacturing practices (GMPs). It provides background on the history and development of GCPs and GMPs, which were created to harmonize standards across countries and ensure safety, quality and efficacy in clinical trials and manufacturing. The core principles of GCPs are described, including ethical treatment of subjects, scientific validity of trials, and quality management. Key aspects of clinical trials such as institutional review boards, investigators, sponsors and essential documents are also covered. The presentation concludes with an introduction to GMPs and descriptions of documentation requirements, production controls and other quality standards they aim to ensure.
services to pharmaceutical companies, biotech and CROs, for human health and animal health, providing consulting, training, validation services, software development, in data management or phamacovigilance.
Tumor Assessment CRF
Data Management
and Drug Safety
services to pharmaceutical companies, biotech and CROs, for human health and animal health, providing consulting, training, validation services, software development, in data management or phamacovigilance.
Implementation of CDISC standards
Statistic analysis or data reports to be used in pharamcovigilance or signal detection
This document provides information about the services offered by a central laboratory for clinical trials and drug discovery. The laboratory provides quality central laboratory services for clinical trials, maintains confidentiality, and meets regulatory standards. It has offered services to leading pharmaceutical companies for preclinical and clinical trials. The services described include in vitro and in vivo ADME studies, cell-based assays, in vivo pharmacology studies, toxicology studies, analytical chemistry services, and more.
CRC provides central laboratory services for clinical trials including maintaining confidentiality and regulatory standards. It has over 10 years experience working with pharmaceutical companies on preclinical and clinical trials. CRC offers a wide range of in vitro and in vivo ADME, pharmacokinetic, toxicology and safety pharmacology studies. It also provides molecular biology, analytical chemistry and other specialized testing services to support drug discovery and development.
1. BAC Good Manufacturing Practices
in Packing, Labeling and Holding of Dietary Supplements
Revised June 2008
Below is an overview of Beyond A Century, Inc.'s current good manufacturing practices program. Our
current program, although close to meeting all requirements of Food and Drug Administration 21 CFR
Part 111, is evolving to meet these new federal regulations at the phase in deadline of August 2010. All
sections of this overview have a corresponding written procedure; SOP; and/or forms for actual
implementation. Full GMP information, procedures, sops and forms can be found in our expanded
manual. This overview serves as a general guideline to the practices and procedures we use in our
operations to insure the integrity and quality of our repackaged products. In addition, BAC uses a
HACCP model to control and monitor critical aspects of our packaging, labeling, and holding of
dietary supplements. Our HACCP model is attached.
I. Personnel
A. Disease Control
i. Any person who has, by medical examination or supervisory observation, an illness or medical
condition such as open lesions or infected wounds that could be a possible source of microbial
contamination shall be removed from the rebottling process so as to prevent adulteration of the
dietary product during packaging and storage. Personnel shall be instructed to report such health
conditions to management.
B. Cleanliness
i. All personnel having direct contact with exposed products, and packaging components, as well
as those individuals utilizing processing equipment and utensils, shall conform to a level of
basic hygiene and personal cleanliness to protect the product against adulteration. These
methods include:
a) Use of lab coats and and/or outer garments that protect against adulteration of product and
equipment.
b) Maintaining personal cleanliness
c) Washing hands thoroughly before starting work and at any other time when the hands may
have become soiled or contaminated.
d) Removing all jewelry.
e) Using gloves specifically designed for laboratory work.
f) Wearing hair nets, caps, beard covers, arm covers and other effective hair restraints.
g) Storing clothing or other personal items outside of processing area.
h) Excluding the consumption of food and drink as well as the use of chewing gum and
tobacco products.
C. Education and Training
i. All BAC laboratory personnel have written job descriptions and have training and experience to
perform their function. All personnel have received GMP and HACCP education and training.
Training is ongoing either as needed or at least quarterly.
D. Supervision
i. The responsibility for assuring compliance by all personnel to these requirements is assigned
2. first to the quality control management unit and then as a team effort by all production staff.
Adequate and proper training, education and experience for all individuals is provided on all
pertinent GMP requirements.
II. Plants and Grounds
A. Grounds
i. Grounds surrounding BAC and its rebottling plant are kept in good condition that will protect
against adulteration of product. These methods include:
a) Properly storing equipment and removing litter, refuse and vegetation within the immediate
vicinity of the buildings that could attract and harbor pests.
b) Maintaining grounds properly that could contribute to product adulteration or infestations of
pests.
c) Disposing of all waste and rubbish in a timely and proper manner to prevent adulteration of
products during rebottling and storage, and to ensure a clean, safe workplace.
B. Plant Construction and Design
i. Plant buildings and structures at BAC are of a sufficient size and construction/design to facilitate
maintenance, cleaning and sanitary operation and to prevent mix ups between different
supplements and products. This includes:
a) Sufficient space for placement or equipment and storage and spacial segregation of
materials.
b) Operating practices that reduce potential for mix-ups and adulteration of in-process or
finished product.
c) Maintenance including cleaning, sanitation, waste disposal and elimination and prevention
of pest infestations.
d) Adequate lighting in production areas.
e) Safety-type light fixtures, fitted with sleeves as necessary to protect against adulteration by
glass.
f) Ventilation and air conditioning when necessary to prevent adulteration of product and
provide a safe and clean operating environment.
g) Screening where necessary to protect again pests.
III. Sanitation of Buildings and Facilities
A. General Maintenance
i. All buildings at BAC are constructed in such a way that all equipment and work and storage
surfaces can be cleaned and sanitized. They are maintained in good repair and cleaned and
sanitized on a regularly scheduled basis.
B. Cleaning and Sanitizing Agents
i. Cleaning and sanitizing agents and pesticides, etc., are used in a safe and effective manner and
are appropriate for their intended use. They are stored in such a way that prevents the
adulteration or contamination of bulk and rebottled products.
C. Pest Control
i. Appropriate measures are taken to prevent infestations of pests.
D. Water Supply
i. BAC water supply is from a drilled well which is tested yearly for potability. The water is tested
to be appropriate for all laboratory and processing procedures.
E. Plumbing is designed, installed and maintained to:
i. Carry sufficient quantities of water throughout the plant
ii. Properly convey sewage and liquid waste from the plant.
iii. Avoid adulteration and contamination of product and equipment and plant.
iv. Prevent the contamination of fresh water.
F. Sewage Disposal
i. BAC's sewage disposal system is the public town sewer system.
G. Toilet Facilities
i. BAC's plant provides its employees with readily accessible and maintained toilet facilities which
are in good repair and sanitized at least daily. Self-closing doors are installed on these facilities
3. to protect from airborne contamination.
H. Hand-washing facilities
i. Hand-washing facilities are convenient and have fresh running water and include effective hand-
cleaning and sanitizing products; sanitary disposable towels; directions on effective hand
washing and anti-recontamination procedures.
I. Rubbish Disposal
i. Refuse containers and rubbish disposal practices protect against product adulteration and the
harbor of pests.
IV.Equipment and Utensils
A. Design and Construction
i. Equipment is installed and maintained so as to facilitate the cleaning of the equipment and
surrounding area.
ii. Equipment and utensils that come into contact with bulk product are constructed appropriately
for this use and are maintained to prevent adulteration and contamination of bulk product, in-
process and finished product by contaminants.
iii. Cleaners and sanitizers used on utensils and equipment are suitable for food processing.
iv. All freezers and refrigerators are fitted with temperature gages and are monitored continually.
B. Sanitation of Equipment and Utensils
i. All equipment and utensils are cleaned as frequently as necessary using appropriate cleaning and
sanitizing agents and stored in covered containers.
ii. Cleaning logs are maintained and reviewed on a regular basis.
V. Quality Control and Laboratory Operations
A. Quality Control Operations
i. Quality control operations are employed to assure dietary supplements conform to specifications
of purity, quality and composition and that packaging materials are safe for their intended
purpose.
a) BAC relies on established suppliers who supply certificates of analysis with all products.
b) We require our suppliers to set specifications and test or confirm testing of products for
compliance to specified identity, purity, strength, composition.
c) BAC certifies suppliers through an in-house certification program.
• Because BAC packages and labels dietary supplements that arrive in their final form in
bulk, we rely on information received from the supplier/manufacturer. We continually
assess the reliability and quality of these suppliers to assure product quality.
d) BAC employs identity examinations on incoming lots of bulk products to assure they are
consistent with the COA and purchase order.
e) Upon receiving, items are examined and compared to their certificate of analysis and
historical samples and an positive identification is made. Identity specifications, purity,
quality and composition are documented in the supplier's certificate of analysis.
f) BAC's GMP program is directed toward process controls and rigorous examinations
throughout the bottling and labeling process to preserve the integrity, purity, quality and
composition of supplements.
g) BAC periodically sends rebottled products for independent purity testing as a means of
testing our process controls and verifying our suppliers' quality.
B. Quality Control Unit
i. A quality control unit consisting of management and production staff has the responsibility of:
a) approving or rejecting all procedures, specifications, test methods and results that impact
the purity, quality and composition of an ingredient or product.
b) Approving or rejecting all components, packaging materials, labeling and finished products
including any contract-manufactured products.
c) Assuring that completed production records are reviewed and product is approved for
distribution.
d) Establishing procedures for changing and revising all documentation
e) Reviewing and approving changes to documentation
4. f) Assuring the most current revision of all documentation is in use at all times.
C. In house and/or Contract Laboratories
i. In-house and contract manufacturers must conform to all FDA & BAC GMP standards.
D. Examination Methods
i. Consistent with FDA cGMP regulations, BAC performs identity examinations on 100% of
incoming batches of bulk products to insure that the product received is consistent with our
purchase orders and COAs.
ii. Finished products are examined to insure that the finished products meet all specifications.
E. Laboratory Records
i. All records from product examinations are maintained with samples and in a separate test log.
F. Shelf Life
i. All products bear a shelf life and expiration date based on accompanying certificate of analysis.
Re-certifications are requested from bulk product suppliers if needed.
VI. Production and Process Controls
A. Master Production and Control Records
i. Master production and control records are maintained either on computer or on paper or in
combination detailing a complete list of bulk products and their suppliers, amounts of bulk
products in each finished product, packaging components, labeling information detailing the
amount and potency of each bulk product in each unit, statements of theoretical weight and its
relation to actual yield and the acceptable range beyond which investigations are initiated. Most
information is integrated into the MBPR batch record.
B. Batch and Control Records
i. A master batch record is used for each batch of rebottled product which includes:
a) dates and times
b) Specific identity, including lot number, of each supplement used.
c) Weight or measure of each bulk product
d) quality control of each step of the packaging process.
e) Statements of theoretical and actual yield
f) packaging components used.
g) Labeling information and sample of label
h) Identification of production staff involved
i) Statements of deviations and resolutions, if applicable
C. Handing and Storage of bulk products, In process materials and re-work
i. Material rework is generally only performed if the items have been stored with BAC
continuously (we generally do not receive material back and reprocess it – it is restocked if
package integrity is evident and otherwise destroyed).
ii. Reworks generally occur only under the following circumstances:
a) A packaging mistake has been made in regards to container size. In this case the product is
repackaged under a contiguous process of re bottling.
b) Packaging containers are reused after being sanitized.
D. Packaging Operations
i. All inspection, packaging and storage of BAC products are conducted in accordance with
sanitation principles in a manner that protects against adulteration and contamination.
ii. BAC bulk products, packaging materials, in process materials and finished products are
effectively spatially and otherwise segregated.
iii. Because BAC repackaging is done without the use of automated machinery, care is taken for
production workers to visually inspect in-process materials to protect against the inclusion of
extraneous materials in the product.
iv. Adulterated or defective material is quarantined and disposed of in a timely fashion.
v. All steps of the packaging and labeling process from receiving through sampling, production,
labeling and stocking of shelves is documented by written procedures.
E. Packaging and Labeling Operations
5. i. Packing and labeling of products at BAC is performed to prevent adulteration and misbranding.
ii. Labels for each product are not retained in hard copy form. Extra labels are destroyed after each
batch run to prevent misbranding. This is documented on the master batch record.
iii. All labels are checked and rechecked for accuracy and inclusion of correct lot number for batch
identification.
VII. Warehousing, Distribution and Post-Distribution Procedures
A. Storage and Distribution
i. Storage of all finished product at BAC is done under conditions that protect the product from
physical, chemical and biological adulteration as well as package product integrity.
ii. Distribution records are maintained as part of the BAC retail database and program and extend
back at least 1 year beyond the expiration or shelf life of the products.
B. Reserve Samples
i. Reserve samples are taken for BAC bulk products and retained at least one year past the
expiration date of the product. BAC samples are attached to the manufacturer's certificate of
analysis in a zip lock bag and stored in a suitable environment. Samples are in sufficient
quantity to perform necessary examinations and other testing if required. Samples of
finished/labeled products are also kept and attached to the master batch sheet.
C. Records Retention
i. All records pertaining to the receiving, holding, repackaging, and distribution of dietary
supplements are retained for at least one year past the expiration date of the product.
D. Written Recall Procedures
i. Written recall procedures for BAC labeled products are included in our GMPs and call for a
specific set of protocols to identify and contact customers, batches implicated and notification to
the FDA.
E. Complaint Files
i. Customer Complaint Records are maintained in physical hard copy form using a pre-printed
customer complaint record (which includes all pertinent customer and product information) and
also in a computer database. These records are permanently retained in computer form and
physically retained at least one year after the expiration date of the product involved.
F. Returned Products
i. Returned products are spatially segregated and inspected before either destroying or restocking.
Opened product is never reworked or restocked.
G. Product Salvaging
i. Products held by BAC that have been subjected to improper storage conditions are destroyed.
6. Beyond A Century, Inc.
173 Lily Bay Road
Greenville, ME 04441
Rev. June 2008
HACCP Plan for Receiving, Sampling, Holding, Repackaging and Shipment of
Bulk Nutritional Supplements.
Beyond A Century, Inc., along with a rigorous GMP program, utilizes a safety system known as
Hazard Analysis and Critical Control Point (HACCP) to guide and monitor its packaging and labeling
processes. By adopting HACCP, the occurrence of food-borne hazards is reduced; resulting in
improved public health protection, increased consumer confidence and overall business success.
The concept of HACCP is based upon seven basic principles.
1. Analysis of workplace hazards
2. Identification of Critical Control Points
3. Establishment of Critical Limits
4. Monitoring of Critical Control Points
5. Application of Corrective Actions
6. Verification Procedures
7. Documentation of the System
Beyond A Century, Inc. repackages over 200 bulk nutritional supplements. These
supplements are repackaged into 20 to 1,000 gram sizes. The bulk materials and
repackaged bottles are intended to be stored at room temperature, average humidity. The
repackaged items are prepared for sale/use using a detailed set of Good Manufacturing
Practices (GMPs) as documented in Beyond A Century, Inc.’s GMP manual.
ALL PROCEDURES ARE AIMED AT PREVENTING MISBRANDING;
ADULTERATION AND CROSS CONTAMINATION!
Part I:Analysis and Identification of Potential Hazards
Part II: Identification of Critical Control Points (CCP)
7. Part III: Monitoring of CCPs
Part IV: Corrective Actions for CCP Failure
Part V: Verification and Monitoring of HACCP Plan
Part VI: Record Keeping and Documentation
Diagram I: Flow chart for BAC HACCP Plan
8. Analyze and Identify Potential Hazards
I Biological:
Receiving: Potential contamination from loss of package integrity
Sampling: Potential contamination from opening
Storage: Improper storage procedure
Production: Potential cross contamination/adulteration
Shipping: Improper packing/shipping procedures
II Chemical:
Receiving: Potential contamination from loss of package integrity
Sampling: Potential contamination from opening
Storage: Improper storage procedure
Production: Potential cross contamination/adulteration
Shipping: Improper packing/shipping procedures
III Physical:
Receiving: Improper unloading/moving procedure
Sampling: Potential contamination from opening
Storage: Improper moving/storing
Production: Potential cross contamination/adulteration
Shipping: Improper packing/shipping procedures
9. Identify Critical Control Points
I Receiving: Unloading and receiving procedures – see GMP SOP:
Receiving Bulk products; Form RRMS. All received products are inspected
for integrity, cleanliness of packaging. Packages are wiped down as
needed to prevent contamination from outside sources. Critical limits
established per GMPs.
II Sampling: See GMP SOP: Bulk Product Receiving and Examination
Log; Receiving Bulk product; Form RRMS. Items are examined by
management to insure that the product ordered is consistent with product
received and accompanying COA. If product is accepted, sample is taken
and product is reclosed and sent to storage. Critical limits established per
GMPs.
III Storage: See GMP SOP Pest Control; Form PEST; SOP Cleaning
Operations; Form ML; Policy: Sanitation of Buildings and Facilities. Items
are stored in warehouse storeroom which is maintained in accordance
with GMPs. Items are stored off floor level to reduce risk to acceptable
levels of contamination/adulteration. Items stored to prevent cross
contamination and product confusion. Critical limits established per
GMPs. Items that are allergens are marked with identifying tape.
IV Production: See GMP SOP: Lab Quality Control; Daily Production;
Production Area Clean-up; Form MBPR. Selecting Product; Comparing
against certificate of analysis and inspection of product; Production Run;
Capping; Labeling; Final Quality Control Check. All points are addressed
by Form: MBPR to ensure bulk product identity, purity and finished
product identity, purity, weight, labeling and overall quality. Critical limits
established per GMPs. Periodically send rebottled and labeled product to
independent laboratory for purity testing.
V Shipping: See GMP SOP: Prepacking Procedures and SOP: Order
Packing. Packing and shipping procedures designed to minimize risk to
acceptable levels of product contamination/adulteration in shipping
process. Critical limits established per GMPs.
10. Monitoring Of Critical Control Points (CCP)
I Receiving: Monitoring procedures done with each occurrence.
II Sampling: Monitoring procedures done with each occurrence.
III Storage: Continuous. Facilities inspected and maintained per GMPs
(Policy: Sanitation of Buildings and Facilities.)
IV Production: Continuous per GMPs. Additional QC verification added
to MBPR to include all production steps. Spot checks for compliance
instituted October 2006.
V Shipping: Continuous per GMPs.
11. Corrective Actions for CCP Failure
I Receiving: Established per GMPs; product is rejected and quarantined
and management notified to replace rejected product. (See GMP: Form
MRN)
II Sampling: Established per GMPs; product is rejected and quarantined
and management notified to replace rejected product. (See GMP: Form
MRN)
III Storage: Established per GMPs; facilities are inspected, cleaned and
deficiencies addressed immediately. If product is affected, product is
quarantined and referred to management for replacement/disposal.
IV Production: Established per GMPs; if product does not meet
specifications at any point in the production process, Material Rejection
Notice is completed and referred to management for
replacement/disposal/reworking.
V Shipping: Established per GMPs; if product is affected, Material
Rejection Notice is completed and referred to management for
replacement/disposal/correction. Employee brings shipping procedure to
attention of management for SOP revision (See GMP: Form SOP Revision)
Verification and Monitoring of HAACP Plan
I Routine Quarterly Review SOP/Retraining
II GMP/HAACP Cross Check Plan
Record Keeping and Documentation of HAACP Plan
I SOPs and Checklists for Review of HAACP Plan
II Corrective Action File
12. FlowDiagram
BAC HACCP Plan
Step 1: Receive Bulk Product
Accept,
Proceed to 2.
Reject
Item Quarantined; Form MRN;
Referred to management
Step 2: Sample Bulk Product;
Identify; Periodically Test for Purity
Step 3: Store Bulk Product
Step 4: Repackage Bulk Product
Step 5: Stock and Ship Finished
Product
Accept, Proceed to step 3 Reject
Item Quarantined; Form MRN;
Referred to management
Accept, Proceed to Step 4 Rejection/Storage Problem
If product affected, Item Quarantined; Form
MRN; Referred to management; Policy/SOP
revision
Accept, Proceed to Step 5 Rejection of in process material
Item Quarantined; Form MRN; Referred to
management
Policy/SOP revision/Retraining
Accept, Ship item. Process Complete
Rejection in Stocking/Shipping
Process
Form MRN; Referred to management
Policy/SOP revision/Retraining